IONIS Pharmaceuticals Inc., 10% Owner at AKCEA THERAPEUTICS, INC. (AKCA), bought 29,333,332 shares at $18.75 ($400.0M) on 2018-04-17, disclosed to the SEC on 2018-04-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 8,000,000 | $0 | 0.0% |
| 2 | $18.75 | 10,666,666 | $200.0M | 50.0% |
| 3 | $18.75 | 10,666,666 | $200.0M | 50.0% |
| Total | $13.64 avg | 29,333,332 | $400.0M | 100% |
| Filing → |